Article Details
Retrieved on: 2024-02-22 13:17:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioNTech holds the exclusive worldwide commercialization rights for this product candidate. BNT316/ONC-392 is currently being evaluated in multiple ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here